One explanation of the asthma paradox: inhibition of natural anti-inflammatory mechanism by β2-agonists

[1]  C. Print,et al.  Regular inhaled beta-agonist treatment in bronchial asthma , 1990, The Lancet.

[2]  S. Holgate,et al.  Protection against allergen-induced asthma by salmeterol , 1990, The Lancet.

[3]  P. Howarth,et al.  Myofibroblasts and subepithelial fibrosis in bronchial asthma. , 1990, American journal of respiratory cell and molecular biology.

[4]  C. van Weel,et al.  Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol. , 1990, The Journal of allergy and clinical immunology.

[5]  M. Tanemura,et al.  Hyperreactive site in the airway tree of asthmatic patients revealed by thickening of bronchial muscles. A morphometric study. , 1990, The American review of respiratory disease.

[6]  M. Bernfield,et al.  Endothelial heparan sulfate proteoglycan. I. Inhibitory effects on smooth muscle cell proliferation. , 1990, American journal of respiratory cell and molecular biology.

[7]  G. Gleich,et al.  Sequestration of eosinophil major basic protein in human mast cells. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[8]  S. Holgate,et al.  The effect of an increase in inhaled allergen dose after rimiterol hydrobromide on the occurrence and magnitude of the late asthmatic response and the associated change in nonspecific bronchial responsiveness. , 1989, The American review of respiratory disease.

[9]  P. Revell,et al.  EFFECT OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ON THE COURSE OF OSTEOARTHRITIS , 1989, The Lancet.

[10]  G. Caughey.  Roles of mast cell tryptase and chymase in airway function. , 1989, The American journal of physiology.

[11]  N. Pearce,et al.  PRESCRIBED FENOTEROL AND DEATH FROM ASTHMA IN NEW ZEALAND, 1981-83; CASE-CONTROL STUDY , 1989, The Lancet.

[12]  S. Holgate,et al.  SUBEPITHELIAL FIBROSIS IN THE BRONCHI OF ASTHMATICS , 1989, The Lancet.

[13]  S. Holgate,et al.  Cellular events in the bronchi in mild asthma and after bronchial provocation. , 1989, The American review of respiratory disease.

[14]  D. Loegering,et al.  Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. , 1989, The American review of respiratory disease.

[15]  R. Stenling,et al.  Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids. , 1988, The European respiratory journal.

[16]  C. Parish,et al.  Inhibition of allergic encephalomyelitis in rats by treatment with sulfated polysaccharides. , 1988, Journal of immunology.

[17]  N. Flavahan,et al.  The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity. , 1988, The Journal of allergy and clinical immunology.

[18]  A. Tattersfield,et al.  REBOUND INCREASE IN BRONCHIAL RESPONSIVENESS AFTER TREATMENT WITH INHALED TERBUTALINE , 1988, The Lancet.

[19]  M. Anne,et al.  Influence of Heparin and a Low Molecular Weight Heparin Fraction of the Leukocytes in an Experimental Venous Thrombosis Model , 1987, Journal of leukocyte biology.

[20]  R. Simon,et al.  Heparin‐like anticoagulants in asthma , 1987, Allergy.

[21]  R. Diegelmann,et al.  Heparin modulates human intestinal smooth muscle cell proliferation, protein synthesis, and lattice contraction. , 1987, Gastroenterology.

[22]  C. Berry,et al.  Diminished atherosclerotic arterial calcifications in asthma , 1987, Allergy.

[23]  H. Neijens,et al.  Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. , 1987, The Journal of allergy and clinical immunology.

[24]  M. Church,et al.  Inhibition of IgE‐dependent histamine release from human dispersed lung mast cells by anti‐allergic drugs and salbutamol , 1987, British journal of pharmacology.

[25]  P. Howarth,et al.  The mast cell as a primary effector cell in the pathogenesis of asthma. , 1986, The Journal of allergy and clinical immunology.

[26]  P. Howarth,et al.  Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulating mediator responses to allergen bronchial provocation in asthma. , 2015, The American review of respiratory disease.

[27]  H. Sluiter,et al.  Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. , 1985, The Journal of allergy and clinical immunology.

[28]  J. Kemp,et al.  Adverse effects and complications of treatment with beta-adrenergic agonist drugs. Committee on drugs, the American Academy of Allergy and Immunology. , 1985, The Journal of allergy and clinical immunology.

[29]  A. Eldor,et al.  The Inhibitory Effect of Heparin and Related Glycosaminoglycans on Neutrophil Chemotaxis , 1984, Thrombosis and Haemostasis.

[30]  B. Benacerraf,et al.  Inhibition of delayed-type hypersensitivity by heparin depleted of anticoagulant activity. , 1983, Cellular immunology.

[31]  D. Metcalfe,et al.  Analysis of the effect of mast cell granules on lymphocyte blastogenesis in the absence and presence of mitogens: identification of heparin as a granule-associated suppressor factor. , 1983, Journal of immunology.

[32]  E. P. Brestel,et al.  Heparin and other sulfated polysaccharides as scavengers of superoxide , 1982 .

[33]  T. Stokes,et al.  Prospects for an oral Intal. , 1981, British journal of diseases of the chest.

[34]  J. Holbrook,et al.  The multiple complexes formed by the interaction of platelet factor 4 with heparin. , 1980, The Biochemical journal.

[35]  D. Loegering,et al.  Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. , 1980, Laboratory investigation; a journal of technical methods and pathology.

[36]  Jean Carr,et al.  The anti-inflammatory action of heparin: heparin as an antagonist to histamine, bradykinin and prostaglandin E1. , 1979, Thrombosis research.

[37]  J. Cox.  Disodium cromoglycate. Mode of action and its possible relevance to the clinical use of the drug. , 1971, British journal of diseases of the chest.

[38]  L. Lichtenstein,et al.  Histamie Release in vitro: Inhibition by Catecholamines and Methylxanthines , 1968, Science.

[39]  B. Benacerraf,et al.  Effect of anticoagulants on delayed hypersensitivity reactions. , 1967, Journal of immunology.

[40]  D. Dolowitz,et al.  THE USE OF HEPARIN IN THE CONTROL OF ALLERGIES. , 1965, Annals of allergy.

[41]  O. B. Williams,et al.  Further Studies on the Influence of Heparin on Anaphylactic Shock in the Guinea Pig , 1928, The Journal of Immunology.